Company / Financials
Picard Medical, Inc. Financials
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$4.9M
FY2025 · NaN% YoY
Net Income
-$27.0M
FY2025 · NaN% YoY
Profit Margin
-546.6%
FY2025 · net income / revenue
ROE
-712.6%
FY2025 · return on equity
Total Assets
$22.5M
FY2025
Total Debt
-
FY2025
Equity
$3.8M
FY2025
ROA
-119.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$4.9MNet Income HistoryProfit after all expenses and taxes-$27.0MGross Profit HistoryRevenue minus cost of goods sold-$204.0KCost of Revenue HistoryDirect costs of producing goods and services sold$5.1MOperating Income HistoryProfit from core business operations before interest and taxes-$13.3MSG&A Expense HistorySelling, general, and administrative expenses$10.0MR&D Expense HistoryResearch and development spending$3.0MIncome Tax HistoryTotal income tax expense$35.0KEPS (Basic) HistoryBasic earnings per share-$2.99Shares Outstanding HistoryWeighted average diluted shares outstanding7.9M